Article Cited by others

REVIEW ARTICLE

Pharmacovigilance in Italy: An overview

Mazzitello Carmela, Esposito Stefania, De Francesco Adele E, Capuano Annalisa, Russo Emilio, De Sarro Giovambattista

Year : 2013| Volume: 4| Issue : 5 | Page no: 20-28

   This article has been cited by
 
1 Adverse drug reactions reporting in Calabria (Southern Italy) in the four-year period 2011-2014: impact of a regional pharmacovigilance project in light of the new European Legislation
Christian Leporini,Giuseppina Marrazzo,Laura Mumoli,Stefania Esposito,Luca Gallelli,Giovanna Mangano,Giacomino Brancati,Emanuela Adele De Francesco,Emilio Russo,Giovambattista De Sarro
Expert Opinion on Drug Safety. 2017; : 1
[Pubmed]  [Google Scholar] [DOI]
2 Interstitial lung disease induced by fluoxetine: Systematic review of literature and analysis of Vigiaccess, Eudravigilance and a national pharmacovigilance database
Arianna Deidda,Claudia Pisanu,Laura Micheletto,Alberto Bocchetta,Maria Del Zompo,Maria Erminia Stochino
Pharmacological Research. 2017; 120: 294
[Pubmed]  [Google Scholar] [DOI]
3 Risk of gastrointestinal complications associated to NSAIDs, low-dose aspirin and their combinations: Results of a pharmacovigilance reporting system
Concetta Rafaniello,Carmen Ferrajolo,Maria Giuseppa Sullo,Maurizio Sessa,Liberata Sportiello,Antonio Balzano,Francesco Manguso,Maria Luisa Aiezza,Francesco Rossi,Carmelo Scarpignato,Annalisa Capuano
Pharmacological Research. 2016; 104: 108
[Pubmed]  [Google Scholar] [DOI]
4 New era in treatment options of chronic hepatitis C: focus on safety of new direct-acting antivirals (DAAs)
Cristina Scavone,Liberata Sportiello,Concetta Rafaniello,Annamaria Mascolo,Maurizio Sessa,Francesco Rossi,Annalisa Capuano
Expert Opinion on Drug Safety. 2016; 15(sup2): 85
[Pubmed]  [Google Scholar] [DOI]
5 The “Fluad Case” in Italy: Could it have been dealt differently?
Miriam Levi,Ersilia Sinisgalli,Chiara Lorini,Francesca Santomauro,Martina Chellini,Paolo Bonanni
Human Vaccines & Immunotherapeutics. 2016; : 00
[Pubmed]  [Google Scholar] [DOI]
6 No substantial gender differences in suspected adverse reactions to ACE inhibitors and ARBs: results from spontaneous reporting system in Campania Region
Liberata Sportiello,Concetta Rafaniello,Maria Giuseppa Sullo,Mihaela Nica,Cristina Scavone,Francesca Futura Bernardi,Delia Maria Colombo,Francesco Rossi
Expert Opinion on Drug Safety. 2016; 15(sup2): 101
[Pubmed]  [Google Scholar] [DOI]
7 Patterns of Adverse Drug Reactions in Different Age Groups: Analysis of Spontaneous Reports by Community Pharmacists
Yun Mi Yu,Wan Gyoon Shin,Ju-Yeun Lee,Soo An Choi,Yun Hee Jo,So Jung Youn,Mo Se Lee,Kwang Hoon Choi,Anny Fortin
PLOS ONE. 2015; 10(7): e0132916
[Pubmed]  [Google Scholar] [DOI]
8 Strategy support for the Post-Market Monitoring (PMM) of GM plants: Review of existing PMM strategies developed for the safety assessment of human and animal health
EFSA Supporting Publications. 2015; 12(1)
[Pubmed]  [Google Scholar] [DOI]
9 Reporting rates for severe hypersensitivity reactions associated with prescription-only drugs in outpatient treatment in Germany
Bernhardt Sachs,Wilma Fischer-Barth,Hans Friedrich Merk
Pharmacoepidemiology and Drug Safety. 2015; 24(10): 1076
[Pubmed]  [Google Scholar] [DOI]
10 Indications of newer and older anti-epileptic drug use: findings from a southern Italian general practice setting from 2005-2011
Domenico Italiano,Annalisa Capuano,Angela Alibrandi,Rosarita Ferrara,Angelo Cannata,Gianluca Trifirņ,Janet Sultana,Carmen Ferrajolo,Michele Tari,Daniele Ugo Tari,Margherita Perrotta,Claudia Pagliaro,Concita Rafaniello,Edoardo Spina,Vincenzo Arcoraci
British Journal of Clinical Pharmacology. 2015; 79(6): 1010
[Pubmed]  [Google Scholar] [DOI]
11 Adherence to therapy and adverse drug reactions: is there a link?
Christian Leporini,Giovambattista De Sarro,Emilio Russo
Expert Opinion on Drug Safety. 2014; 13(S1): 41
[Pubmed]  [Google Scholar] [DOI]
12 Improvement of patient adverse drug reaction reporting through a community pharmacist-based intervention in the Campania region of Italy
Elisabetta Parretta,Concetta Rafaniello,Lara Magro,Anna Coggiola Pittoni,Liberata Sportiello,Carmen Ferrajolo,Annamaria Mascolo,Maurizio Sessa,Francesco Rossi,Annalisa Capuano
Expert Opinion on Drug Safety. 2014; 13(S1): 21
[Pubmed]  [Google Scholar] [DOI]
13 Retapamulin Prescriptions and Monitored Off-Label Use
Linda M. Mundy,Tim Sampson,John W. Logie
Pediatric Drugs. 2014; 16(4): 331
[Pubmed]  [Google Scholar] [DOI]
14 Type III or allosteric kinase inhibitors for the treatment of non-small cell lung cancer
Morena Fasano,Carminia Maria Della Corte,Raffaele Califano,Annalisa Capuano,Teresa Troiani,Erika Martinelli,Fortunato Ciardiello,Floriana Morgillo
Expert Opinion on Investigational Drugs. 2014; : 1
[Pubmed]  [Google Scholar] [DOI]
15 Pattern of Statin Use in Southern Italian Primary Care: Can Prescription Databases Be Used for Monitoring Long-Term Adherence to the Treatment?
Carmen Ferrajolo,Vincenzo Arcoraci,Maria Giuseppa Sullo,Concetta Rafaniello,Liberata Sportiello,Rosarita Ferrara,Angelo Cannata,Claudia Pagliaro,Michele Giuseppe Tari,Achille Patrizio Caputi,Francesco Rossi,Gianluca Trifirņ,Annalisa Capuano,Alberico Catapano
PLoS ONE. 2014; 9(7): e102146
[Pubmed]  [Google Scholar] [DOI]
16 Pharmacovigilance in Calabria (Italy): Local experiences resonate international relevance
Russo, E., De Sarro, G.
Journal of Pharmacology and Pharmacotherapeutics. 2013; 4(1): s1-s3
[Pubmed]  [Google Scholar]
17 Limitations and obstacles of the spontaneous adverse drugs reactions reporting: Two "challenging" case reports
Palleria, C., Leporini, C., Chimirri, S., (...), Scicchitano, F., Russo, E.
Journal of Pharmacology and Pharmacotherapeutics. 2013; 4(1): S66-S72
[Pubmed]  [Google Scholar]
18 Informatics applied to pharmacovigilance: Future perspectives
Menniti, M., Menniti, A., Patanč, M., Aiello, R., Russo, E.
Journal of Pharmacology and Pharmacotherapeutics. 2013; 4(1): S43-S46
[Pubmed]  [Google Scholar]

 

Read this article